A Simple Temperature‐Controlled Method for Preserving Viability in Human Pluripotent Stem Cell‐Derived Retinal Organoids During Shipment
- 1Department of Ophthalmology, CellSight Ocular Stem Cell and Regeneration Research Program, Sue Anschutz‐Rodgers Eye Center University of Colorado Anschutz School of Medicine Aurora Colorado USA
- 2Department of Biology The University of Akron Akron Ohio USA
Abstract
Retinal organoids derived from human induced pluripotent stem cells (hiPSCs) hold significant promise as a tool for advancing our understanding of human retinal development and disease, as well as for the development of therapeutic strategies. However, research utilizing hiPSC‐derived retinal organoid models has been constrained by logistical challenges. A notable issue is the increasing need for scientific collaboration, as experiments requiring coordination across multiple institutions often rely on the shipping of live tissues. Transporting retinal organoids over long distances without adequate climate control can lead to tissue degradation, which may interfere with histopathological analyses and impact the results of drug screening assays. Retinal organoids are most often shipped either without temperature regulation or with lithium‐ion battery‐powered ambient environment systems, which are heavily regulated by standard shipping companies, thus raising costs and introducing further logistical complications. In this study, we developed and evaluated a straightforward, cost‐effective, and dependable temperature‐controlled technology for shipping retinal organoids that can maintain adequate shipping temperature in colder months and decrease temperature fluctuations during shipment year‐round, preserving organoid tissue structure and viability.
Related
- Development-inspired approach for the derivation of functional and transplantable salivary gland organoids from human pluripotent stem cells.
- Regenerative therapies using pluripotent stem cell-derived retinal organoids
- Transcriptomic analysis of human induced pluripotent stem cell cardiomyocytes and myocardial tissue reveals novel role for miR-9-5p in hypertrophic cardiomyopathy
- Directed differentiation with mechanical simulation enhances alveolar-like features in human pluripotent stem cell-derived lung epithelium
- A genome-scale CRISPRi perturbation atlas of human induced pluripotent stem cells
BibTeX
@article{cusato2026simple,
title = {{A Simple Temperature‐Controlled Method for Preserving Viability in Human Pluripotent Stem Cell‐Derived Retinal Organoids During Shipment}},
author = {Karen Cusato and Matthew J. Tarchick and Michael Ha and Jessica R. Onyak and Aimee C. Saunders and Joseph A. Brzezinski IV and Jordan M. Renna and M. Natalia Vergara},
journal = {FASEB BioAdvances},
year = {2026},
month = oct,
doi = {10.1096/fba.2026-00043},
url = {https://doi.org/10.1096/fba.2026-00043},
note = {CC BY},
}
RIS
TY - JOUR
TI - A Simple Temperature‐Controlled Method for Preserving Viability in Human Pluripotent Stem Cell‐Derived Retinal Organoids During Shipment
AU - Karen Cusato
AU - Matthew J. Tarchick
AU - Michael Ha
AU - Jessica R. Onyak
AU - Aimee C. Saunders
AU - Joseph A. Brzezinski IV
AU - Jordan M. Renna
AU - M. Natalia Vergara
PY - 2026
DA - 2026/10/26
JO - FASEB BioAdvances
DO - 10.1096/fba.2026-00043
UR - https://doi.org/10.1096/fba.2026-00043
AB - Retinal organoids derived from human induced pluripotent stem cells (hiPSCs) hold significant promise as a tool for advancing our understanding of human retinal development and disease, as well as for the development of therapeutic strategies. However, research utilizing hiPSC‐derived retinal organoid models has been constrained by logistical challenges. A notable issue is the increasing need for scientific collaboration, as experiments requiring coordination across multiple institutions often rely on the shipping of live tissues. Transporting retinal organoids over long distances without adequate climate control can lead to tissue degradation, which may interfere with histopathological analyses and impact the results of drug screening assays. Retinal organoids are most often shipped either without temperature regulation or with lithium‐ion battery‐powered ambient environment systems, which are heavily regulated by standard shipping companies, thus raising costs and introducing further logistical complications. In this study, we developed and evaluated a straightforward, cost‐effective, and dependable temperature‐controlled technology for shipping retinal organoids that can maintain adequate shipping temperature in colder months and decrease temperature fluctuations during shipment year‐round, preserving organoid tissue structure and viability.
SN - 2573-9832
ER -